: A new chapter on Enterocolitis and Hepatitis induced by cancer immunotherapy, reflecting the rise of biological treatments in oncology. Microbiota and Probiotics
(Metabolic dysfunction-associated Steatotic Liver Disease), reflecting the shift from the former NAFLD nomenclature. Therapeutic Advances: Updates on new treatments for viral hepatitis
: Guided by Raymond T. Chung, David T. Rubin, and C. Mel Wilcox.